Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Endo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Endo's 2013 CNS (central nervous system) sales performance.

Endo Health Solutions

Will biosimilars ever catch on in the US?

Will biosimilars ever catch on in the US?

The latest example involved Endo Pharmaceuticals paying Impax Laboratories $112m to delay selling a generic version of Opana ER.

UK to add addiction warnings to opioids as use soars

UK to add addiction warnings to opioids as use soars Endo, Teva and Abbott are among other companies also accused of exaggerating the benefits of their products and playing down safety concerns.

Sobi names Holly May VP of sales and marketing, US

Sobi names Holly May VP of sales and marketing, US Prior to her 17-year career at Sanofi, May held various sales positions at DuPont Pharmaceuticals and Endo.

Endo faces industry-first FDA call to pull its opioid painkiller

Endo faces industry-first FDA call to pull its opioid painkiller Endo’s shares dropped to 13.6% following the request and the Irish drug maker said that it’s “evaluating the full range of potential options”. ... Last year, Opana generated sales of $159m for Endo, down from its peak of around $300m and the drug

Valeant's proposed sale of Salix to Takeda 'in jeopardy'

Valeant's proposed sale of Salix to Takeda 'in jeopardy' Salix – a specialist in gastrointestinal treatments – only became part of Valeant last year after a bidding war between the firm and rival suitors including Takeda and Endo.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics